Citadel Advisors »

Akero Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 638k 23.35
2023-09-30 $20M 389k 50.58
2023-06-30 $18M 376k 46.69
2023-03-31 $36M 933k 38.26
2022-12-31 $24M 433k 54.80
2022-06-30 $932k 99k 9.45
2022-03-31 $1.2M 88k 14.19
2021-12-31 $580k 27k 21.15
2021-09-30 $1.1M 47k 22.34
2021-06-30 $2.0M 82k 24.79
2021-03-31 $5.9M 203k 29.03
2020-12-31 $5.8M 225k 25.77
2020-09-30 $1.3M 41k 30.86
2020-06-30 $1.6M 66k 24.92
2020-03-31 $297k 14k 21.21
2019-12-31 $459k 21k 22.17
2019-09-30 $518k 23k 22.30